Hepatitis D
| Hepatitis D | |
|---|---|
| Other names | Hepatitis delta |
| Specialty | Gastroenterology, infectious disease |
| Symptoms | Feeling tired, nausea and vomiting |
| Complications | Cirrhosis |
| Causes | Hepatitis D virus |
| Diagnostic method | Immunoglobulin G |
| Treatment | Antivirals, pegylated interferon alpha |
| Medication | Bulevirtide |
Hepatitis D is a type of viral hepatitis caused by the hepatitis delta virus (HDV). HDV is one of five known hepatitis viruses: A, B, C, D, and E. HDV is considered to be a satellite (a type of subviral agent) because it can propagate only in the presence of the hepatitis B virus (HBV). Transmission of HDV can occur either via simultaneous infection with HBV (coinfection) or superimposed on chronic hepatitis B or hepatitis B carrier state (superinfection).
HDV infecting a person with chronic hepatitis B (superinfection) is considered the most serious type of viral hepatitis due to its severity of complications. These complications include a greater likelihood of experiencing liver failure in acute infections and a rapid progression to liver cirrhosis, with an increased risk of developing liver cancer in chronic infections. In combination with hepatitis B virus, hepatitis D has the highest fatality rate of all the hepatitis infections, at 20%. A recent estimate from 2020 suggests that currently 48 million people are infected with this virus.